Foolish Forecast: Greener Forest Labs
MSN MoneyCentral - Yet after a rocky start, revenues and earnings have grown to record levels because of Forest Labs' stable of other products, including Lexapro, which succeeded Celexa for depression treatment. Last October, Chairman and CEO Howard Solomon said, "We
Source: news.moneycentral.msn.com
Cardiologists warn depression under-treated in heart attack survivors
CNW Group - Another study of depression treatment among heart attack survivors revealed a gap in attitude between males and females. In a study of 17,000 patients in Alberta, Dr. Padma Kaul found that anti-depressant medication (ADM) use is less frequent
Source: www.newswire.ca
Danish shares higher at mid-day led by Bang & Olufsen; Moller-Maersk
Forbes - Lundbeck was up 2 dkr at 164.75, having yesterday been hit by profit-taking following better-than-expected third-quarter sales of its Lexapro depression treatment in the US, announced earlier in the week. Nordea Bank was up 0.75 dkr at 89.75, Sydbank
Source: www.forbes.com
Click here for more information about depression statistics depression statistics
<< Home